Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
IDEAYA Biosciences logo — Synthetic lethality precision medicine oncology company purs...

IDEAYA Biosciences

Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision medicine targets.

Founded 2015 United States South San Francisco, United States 264 employees Post Ipo Equity Total: $694.10M Biotechnology, Health Care +1

General Information

Company Name IDEAYA Biosciences
Founded Year 2015
Location United States South San Francisco, United States +1
Founders / Decision Makers
Team member Team member Team member
Employees 264
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when IDEAYA Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IDEAYA Biosciences

IDEAYA Biosciences is a biotechnology and healthcare startup founded in 2015, with its headquarters in South San Francisco, California. The company focuses on oncology and precision medicine, aiming to develop targeted therapeutics utilizing molecular diagnostics for patient selection. Their primary focus is on synthetic lethality, an emerging class of precision medicine targets.

IDEAYA recently secured a significant $125.00M Post-IPO Equity investment on 24 October 2023, indicating investor confidence in the company's approach and potential. With a commitment to pioneering first-in-class and/or best-in-class therapeutics, IDEAYA Biosciences is positioned to make a significant impact within the oncology and precision medicine space.

Taxonomy: Precision Medicine, Oncology, Synthetic Lethality, Therapeutics, DNA Damage and Repair, Immunotherapy Response, Immuno-Oncology, Targeted Therapeutics, Molecular Diagnostics, Small Molecule Drug Discovery, Cancer Biology, Patient Populations, Headquarters in South San Francisco, Breakthrough Medicines

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 09 Jul 2024
Post-IPO Equity •••••• - 24 Oct 2023
Post-IPO Equity •••••• - 14 Sep 2022
Post-IPO Equity •••••• - 07 Jul 2021
Series B •••••• 10
Investor Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		15 Mar 2018

View All 7 Funding Rounds

IDEAYA Biosciences Alternatives & Competitors

IDEAYA Biosciences vs
Ashvattha Therapeutics, Inc.
Ashvattha Therapeutics, Inc. United States

Harnessing the power of hydroxyl dendrimers to create a new class of disease cell-targeted precision...

Series B
24 employees
Biotechnology, Health Care
Compare IDEAYA Biosciences vs Ashvattha Therapeutics, Inc.
IDEAYA Biosciences vs
Enliven Therapeutics
Enliven Therapeutics United States

Discovering and developing next generation precision oncology therapeutics

IPO
78 employees
Biotechnology, Health and Wellness
Compare IDEAYA Biosciences vs Enliven Therapeutics
IDEAYA Biosciences vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
Compare IDEAYA Biosciences vs Synnovation Therapeutics

FAQ About IDEAYA Biosciences

Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision medicine targets.
IDEAYA Biosciences was founded in 2015.
IDEAYA Biosciences is headquartered in South San Francisco, United States.
IDEAYA Biosciences operates in the following industries: Biotechnology, Health Care, Health and Wellness.
IDEAYA Biosciences has approximately 264 employees.
IDEAYA Biosciences has completed 7 funding rounds, raising a total of $694.10M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to IDEAYA Biosciences include Ashvattha Therapeutics, Inc., Enliven Therapeutics, Synnovation Therapeutics, Sidewinder Therapeutics, Inc, Feel Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IDEAYA Biosciences and Ashvattha Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IDEAYA Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy